US$ 25.97
glp 1 τι ειναι GLP-1 GLP-1 Medications – Community Education
Description
Nakade, Y., Tsukamoto, K., Iwa, M., Pappas, T

Ongoing research endeavors aim to optimize their therapeutic use, delineate patient-specific treatment paradigms, and explore novel therapeutic applications

Use of an SGLT2 inhibitor lowered the risk for HF hospitalization or CV death compared with adults receiving placebo (HR = 0.77

Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al

Access Issues Shortages and insurance barriers create major obstacles for patients needing GLP-1 medications

2,5,6 Obesity is associated with a unique phenotype of HFpEF associated with distinct structural and hemodynamic alternations compared to those with HFpEF and without obesity
